J Duraj
Impact in
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Glycosylation and Glycoproteins Research 9
- Retinoids in leukemia and cellular processes 7
- Genomics, phytochemicals, and oxidative stress 6
- RNA modifications and cancer 4
- DNA Repair Mechanisms 3
- RNA Interference and Gene Delivery 3
-
- Monoclonal and Polyclonal Antibodies Research 10
- Radiopharmaceutical Chemistry and Applications 9
- Co-authors
- J Sedlák (35 shared papers)Ľuba Hunáková (24 shared papers)Dana Cholujová (7 shared papers)Ján Sedlák (7 shared papers)Juraj Bodo (5 shared papers)Jana Jakubı́ková (7 shared papers)Paulina Gronesova (5 shared papers)Olga Sedlakova (4 shared papers)
- Journals
- Cancer Letters (1 paper)Cancer Immunology Immunotherapy (1 paper)Biochimie (1 paper)Basic & Clinical Pharmacology & Toxicology (1 paper)Chemotherapy (1 paper)
- Partner nations
- SlovakiaUnited StatesAustria
In The Last Decade
J Duraj
50 papers receiving 487 citations
Peers
Comparison fields: 5 of 82
- Biochemistry 30
- Toxicology 16
- Oncology 103
- Molecular Biology 267
- Geriatrics and Gerontology 12
Countries citing papers authored by J Duraj
This map shows the geographic impact of J Duraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Duraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Duraj more than expected).
Fields of papers citing papers by J Duraj
This network shows the impact of papers produced by J Duraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Duraj. The network helps show where J Duraj may publish in the future.
Co-authors
The 25 scholars most cited alongside J Duraj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 50 | |
| 2 | Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. | 2005 | 49 |
| 3 | 2009 | 37 | |
| 4 | 2014 | 36 | |
| 5 | 2014 | 30 | |
| 6 | Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells. | 2006 | 20 |
| 7 | 2006 | 19 | |
| 8 | 1991 | 17 | |
| 9 | 1995 | 17 | |
| 10 | 1994 | 16 | |
| 11 | Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines. | 1999 | 15 |
| 12 | Pentoxifylline stimulates drug-induced apoptosis in leukemic cells. | 1998 | 14 |
| 13 | PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro. | 2002 | 14 |
| 14 | Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors. | 1996 | 13 |
| 15 | 1994 | 11 | |
| 16 | Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin. | 1997 | 9 |
| 17 | Differential sensitivity of ovarian carcinoma cell lines to apoptosis induced by the IMPDH inhibitor benzamide riboside. | 2000 | 9 |
| 18 | Radiation-induced apoptosis and cell cycle alterations in human carcinoma cell lines with different radiosensitivities. | 2000 | 8 |
| 19 | 1988 | 7 | |
| 20 | 1995 | 7 |
About J Duraj
J Duraj is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Organic Chemistry and Oncology, having authored 51 papers that have together received 491 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (9 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Retinoids in leukemia and cellular processes (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), RNA modifications and cancer (4 papers), DNA Repair Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Biochemistry (30 citations), Toxicology (16 citations), Oncology (103 citations), Molecular Biology (267 citations) and Geriatrics and Gerontology (12 citations). J Duraj has collaborated with scholars based in Slovakia, United States and Austria. Frequent co-authors include J Sedlák, Ľuba Hunáková, Dana Cholujová, Ján Sedlák, Juraj Bodo, Jana Jakubı́ková, Paulina Gronesova, Olga Sedlakova, Ladislav Novotný and P Rauko. Their work appears in journals such as Cancer Letters, Cancer Immunology Immunotherapy, Biochimie, Basic & Clinical Pharmacology & Toxicology and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.